Cingulate CEO Shane Schaffer talks about the financing environment for small cap life sciences companies & its recent raise. $CING
#PrecisionTimedRelease #PTR #NASDAQ #Biotech #BioPharma #FDA #FDAApproval #PDUFA #NDA #DrugDelivery #ExtendedRelease #ControlledRelease
youtube.com/shorts/CZ-Cn...

EVP and Chief Commercial Officer Bryan Downey describes Cingulate’s sales and marketing strategy for CTx-1301. $CING #CTx-1301 #ADHD #PrecisionTimedRelease #PTR #NASDAQ #Biotech #BioPharma #FDA #FDAApproval #PDUFA #NDA #DrugDelivery #ExtendedRelease #ControlledRelease
youtube.com/shorts/sVbvZ...

Extended-release ketamine tablets offer new hope for treatment-resistant depression The BEDROC trial found that extended-release ketamine tablets (R-107) significantly improve depressive symptoms in treatment-resistant depression patients, with the 180 mg dose showing the most effica...

Extended-release ketamine tablets offer new hope for treatment-resistant depression 💊🧠🌟 www.news-medical.net/news/2024062... #Depression #MentalHealth #Ketamine #Therapy #ClinicalTrials #Antidepressant #Pharma #MentalWellness #Research #ExtendedRelease @natureportfolio.bsky.social